Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205117006> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4205117006 abstract "Human epidermal growth factor receptor 2 (HER-2) overexpressed breast cancer has traditionally been considered as an aggressive disease with high risk of systemic and brain metastases and poor prognosis. Nowadays, we have many HER-2 targeting treatments that have radically changed patients’ outcomes. Among the oldest ones, trastuzumab, pertuzumab, lapatinib and trastuzumab-emtansine have been for some years the backbone of established therapies. New drugs, such as tucatinib, trastuzumab-deruxtecan, pyrotinib, neratinib and margetuximab, have recently joined the therapeutic arsenal, revolutionizing the therapeutic field of this disease. Many other drugs are currently under development and give hope, with encouraging results to heavily pretreated patients or those with central nervous system metastasis." @default.
- W4205117006 created "2022-01-25" @default.
- W4205117006 date "2021-10-10" @default.
- W4205117006 modified "2023-10-17" @default.
- W4205117006 title "The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer" @default.
- W4205117006 doi "https://doi.org/10.36000/hbt.oh.2021.09.044" @default.
- W4205117006 hasPublicationYear "2021" @default.
- W4205117006 type Work @default.
- W4205117006 citedByCount "0" @default.
- W4205117006 crossrefType "journal-article" @default.
- W4205117006 hasBestOaLocation W42051170061 @default.
- W4205117006 hasConcept C121608353 @default.
- W4205117006 hasConcept C126322002 @default.
- W4205117006 hasConcept C143998085 @default.
- W4205117006 hasConcept C185926286 @default.
- W4205117006 hasConcept C2775930923 @default.
- W4205117006 hasConcept C2777329042 @default.
- W4205117006 hasConcept C2778087150 @default.
- W4205117006 hasConcept C2779134260 @default.
- W4205117006 hasConcept C2779413316 @default.
- W4205117006 hasConcept C2779786085 @default.
- W4205117006 hasConcept C2781164504 @default.
- W4205117006 hasConcept C2908728163 @default.
- W4205117006 hasConcept C530470458 @default.
- W4205117006 hasConcept C71924100 @default.
- W4205117006 hasConceptScore W4205117006C121608353 @default.
- W4205117006 hasConceptScore W4205117006C126322002 @default.
- W4205117006 hasConceptScore W4205117006C143998085 @default.
- W4205117006 hasConceptScore W4205117006C185926286 @default.
- W4205117006 hasConceptScore W4205117006C2775930923 @default.
- W4205117006 hasConceptScore W4205117006C2777329042 @default.
- W4205117006 hasConceptScore W4205117006C2778087150 @default.
- W4205117006 hasConceptScore W4205117006C2779134260 @default.
- W4205117006 hasConceptScore W4205117006C2779413316 @default.
- W4205117006 hasConceptScore W4205117006C2779786085 @default.
- W4205117006 hasConceptScore W4205117006C2781164504 @default.
- W4205117006 hasConceptScore W4205117006C2908728163 @default.
- W4205117006 hasConceptScore W4205117006C530470458 @default.
- W4205117006 hasConceptScore W4205117006C71924100 @default.
- W4205117006 hasIssue "Issue 9" @default.
- W4205117006 hasLocation W42051170061 @default.
- W4205117006 hasLocation W42051170062 @default.
- W4205117006 hasOpenAccess W4205117006 @default.
- W4205117006 hasPrimaryLocation W42051170061 @default.
- W4205117006 hasRelatedWork W2810369514 @default.
- W4205117006 hasRelatedWork W2895039135 @default.
- W4205117006 hasRelatedWork W3090684381 @default.
- W4205117006 hasRelatedWork W3100248540 @default.
- W4205117006 hasRelatedWork W3123611170 @default.
- W4205117006 hasRelatedWork W3153498716 @default.
- W4205117006 hasRelatedWork W4205117006 @default.
- W4205117006 hasRelatedWork W4206299960 @default.
- W4205117006 hasRelatedWork W4224313646 @default.
- W4205117006 hasRelatedWork W4288926644 @default.
- W4205117006 isParatext "false" @default.
- W4205117006 isRetracted "false" @default.
- W4205117006 workType "article" @default.